Form 4: Lemaitre Vascular Director John A. Roush Reports Acquisition of Dividend Equivalent Rights

Director John A. Roush of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.

Summary

• John A. Roush, a director at Lemaitre Vascular Inc., has reported the acquisition of dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit and performance share unit awards.
• The dividend equivalent rights were acquired on December 5, 2024.
• The rights vest proportionately with the underlying stock awards.
• Each dividend equivalent right is equivalent to one share of Lemaitre Vascular's common stock.
• A total of 2.3714 dividend equivalent rights were acquired across four different grants.

Sentiment

Score: 7

Explanation: The document is a routine filing related to executive compensation. It is neither particularly positive nor negative, but indicates standard corporate governance practices.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of director interests with shareholder value.
• The vesting schedule of the rights is tied to the underlying stock awards, promoting long-term focus.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders acquire or dispose of company securities. It reflects routine compensation practices.

Comparison to Industry Standards

• The use of dividend equivalent rights is a common practice in executive compensation packages within the medical device industry.
• Many companies, such as Medtronic and Stryker, use similar equity-based compensation to align management and shareholder interests.
• The vesting schedules tied to underlying stock awards are also standard practice to encourage long-term performance.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates

Keywords

dividend equivalent rights, Lemaitre Vascular, director, stock awards, LMAT, insider trading, form 4